Detalhe da pesquisa
1.
Real-World Analysis of Nivolumab and Atezolizumab Efficacy in Previously Treated Patients with Advanced Non-Small Cell Lung Cancer.
Pharmaceuticals (Basel)
; 15(5)2022 Apr 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-35631359
2.
Correlation of peripheral blood biomarkers with clinical outcomes in NSCLC patients with high PD-L1 expression treated with pembrolizumab.
Transl Lung Cancer Res
; 10(6): 2509-2522, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-34295658